← Back to all trials
Not Yet Recruiting
NCT07925697
Registry of Relatives and Patients Carrying Pathogenic Germline DDX41 Variants and Emerging New Syndromes
Conditions: Myeloid Neoplasms (AML/MDS)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Enrollment: 525
Sponsor: Groupe Francophone des Myelodysplasies
Location: Centre Hospitalier Argenteuil Argenteuil
Summary
The preDDX registry aims to study germline genetic predispositions to myeloid neoplasms, in particular those associated with pathogenic DDX41 variants and emerging syndromes.
Eligibility Criteria
Inclusion Criteria:
* Male or female
* Age ≥ 18 years
* Presence of a germline variant (pathogenic, likely pathogenic or in a candidate gene)
* Followed in a participating center
* Able and willing to provide written informed consent
Exclusion Criteria:
* No identified or suspected genetic predisposition
* No consent
Source: ClinicalTrials.gov (NCT07925697). StuddyBuddy aggregates publicly available trial information.
